华丽家族(600503.SH)：拟以不超过3亿元参与海和药物的配股融资，每股价格4.75元

Core Viewpoint - The company Huayi Family (600503.SH) plans to invest up to 300 million yuan in Haihe Pharmaceutical's share placement financing, aiming to acquire shares at a price of 4.75 yuan per share, totaling no more than 63.157895 million shares [1] Summary by Relevant Sections - Investment Details - The company intends to participate in Haihe Pharmaceutical's financing with a maximum investment of 300 million yuan [1] - The share price for the new shares is set at 4.75 yuan, allowing for the acquisition of up to 63.157895 million shares [1] - Ownership Implications - Post-investment, the company's ownership stake in Haihe Pharmaceutical is expected to be between 5% and 8.09% [1] - Strategic Objectives - The purpose of this capital increase is to ensure stable operations of the main business while seeking reasonable financial returns [1] - The investment also aims to explore opportunities in emerging industries and development prospects [1]